{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:11:59Z","timestamp":1780359119695,"version":"3.54.1"},"reference-count":22,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"vor","delay-in-days":731,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["RIEKER15PE0"],"award-info":[{"award-number":["RIEKER15PE0"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["SAWICK14PE1"],"award-info":[{"award-number":["SAWICK14PE1"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.jcf.2023.04.015","type":"journal-article","created":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T07:13:15Z","timestamp":1682925195000},"page":"830-835","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Partners in research: The success with therapies research consortium and the CF community unite to improve self-management"],"prefix":"10.1016","volume":"22","author":[{"given":"Gregory S.","family":"Sawicki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Goodman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Callie","family":"Bacon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5077-8636","authenticated-orcid":false,"given":"Lauren","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3441-571X","authenticated-orcid":false,"given":"Jonathan","family":"Greenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Duncan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Frederick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelby","family":"Luebbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia","family":"Mazuera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepika","family":"Polineni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori L.","family":"Stark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6892-3512","authenticated-orcid":false,"given":"Kristin A.","family":"Riekert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jcf.2023.04.015_bib0001","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jcf.2012.12.009","article-title":"Investigators and coordinators of the epidemiologic study of cystic fibrosis. treatment complexity in cystic fibrosis: trends over time and associations with site-specific outcomes","volume":"12","author":"Sawicki","year":"2013","journal-title":"J Cyst Fibros"},{"issue":"2","key":"10.1016\/j.jcf.2023.04.015_bib0002","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jcf.2008.09.007","article-title":"High treatment burden in adults with cystic fibrosis: challenges to disease self-management","volume":"8","author":"Sawicki","year":"2009","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2023.04.015_bib0003","first-page":"7","article-title":"Disease-modifying drug therapy in cystic fibrosis","volume":"26","author":"Harman","year":"2018","journal-title":"Paediatr Respir Rev"},{"issue":"1","key":"10.1016\/j.jcf.2023.04.015_bib0004","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1080\/21556660.2021.1912352","article-title":"Adherence to cystic fibrosis transmembrane conductance regulator (CFTR) modulators: analysis of a national specialty pharmacy database","volume":"10","author":"Mehta","year":"2021","journal-title":"J Drug Assess"},{"issue":"3","key":"10.1016\/j.jcf.2023.04.015_bib0005","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.jcf.2019.09.018","article-title":"Adherence to lumacaftor-ivacaftor therapy in patients with cystic fibrosis in France","volume":"19","author":"Olivereau","year":"2020","journal-title":"J Cyst Fibros"},{"issue":"9","key":"10.1016\/j.jcf.2023.04.015_bib0006","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1080\/13696998.2016.1178125","article-title":"Healthcare resource utilization associated with ivacaftor use in patients with cystic fibrosis","volume":"19","author":"Suthoff","year":"2016","journal-title":"J Med Econ"},{"issue":"9","key":"10.1016\/j.jcf.2023.04.015_bib0007","first-page":"1021","article-title":"Effect of lumacaftor\/ivacaftor on pulmonary exacerbation rates in members with cystic fibrosis in a medicaid population","volume":"25","author":"Tesell","year":"2019","journal-title":"J Manag Care Spec Pharm"},{"key":"10.1016\/j.jcf.2023.04.015_bib0008","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.clnesp.2019.06.004","article-title":"Psychological predictors of nutritional adherence in adolescents with cystic fibrosis","volume":"33","author":"Borschuk","year":"2019","journal-title":"Clin Nutr ESPEN"},{"issue":"1","key":"10.1016\/j.jcf.2023.04.015_bib0009","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1378\/chest.13-1926","article-title":"Pulmonary medication adherence and health-care use in cystic fibrosis","volume":"146","author":"Quittner","year":"2014","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.jcf.2023.04.015_bib0010","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1378\/chest.09-3074","article-title":"Accurate assessment of adherence: self-report and clinician report vs electronic monitoring of nebulizers","volume":"140","author":"Daniels","year":"2011","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.jcf.2023.04.015_bib0011","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jcf.2011.03.005","article-title":"Longitudinal association between medication adherence and lung health in people with cystic fibrosis","volume":"10","author":"Eakin","year":"2011","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2023.04.015_bib0012","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1136\/thoraxjnl-2020-215556","article-title":"Longitudinal effects of ivacaftor and medicine possession ratio in people with the Gly551Asp mutation: a 5-year study","volume":"76","author":"Mitchell","year":"2021","journal-title":"Thorax"},{"issue":"6","key":"10.1016\/j.jcf.2023.04.015_bib0013","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1097\/MCP.0b013e3283659f45","article-title":"The impact of medication adherence on lung health outcomes in cystic fibrosis","volume":"19","author":"Eakin","year":"2013","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.jcf.2023.04.015_bib0014","first-page":"117","article-title":"Strategies to optimize treatment adherence in adolescent patients with cystic fibrosis","volume":"7","author":"Bishay","year":"2016","journal-title":"Adolesc Health Med Ther"},{"issue":"8","key":"10.1016\/j.jcf.2023.04.015_bib0015","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/s11606-012-2037-1","article-title":"A new taxonomy for stakeholder engagement in patient-centered outcomes research","volume":"27","author":"Concannon","year":"2012","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.jcf.2023.04.015_bib0016","series-title":"Behavioral intervention research: designing, evaluating, and implementing","author":"Gitlin","year":"2015"},{"key":"10.1016\/j.jcf.2023.04.015_bib0017","series-title":"Proceedings of the north american cystic fibrosis conference","article-title":"Managing daily life with CF: exploration of patient and parent perspectives [poster presentation]","author":"Oates","year":"2019"},{"key":"10.1016\/j.jcf.2023.04.015_bib0018","series-title":"Proceedings of the perspectives of adults with CF, caregivers, and research team members on compensation for research participation [poster presentation]. North American cystic fibrosis conference","author":"Dunn","year":"2016"},{"issue":"10","key":"10.1016\/j.jcf.2023.04.015_bib0019","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1037\/hea0000161","article-title":"From ideas to efficacy: the ORBIT model for developing behavioral treatments for chronic diseases","volume":"34","author":"Czajkowski","year":"2015","journal-title":"Health Psychol"},{"issue":"6","key":"10.1016\/j.jcf.2023.04.015_bib0020","doi-asserted-by":"crossref","first-page":"e37677","DOI":"10.2196\/37677","article-title":"Assessing the Clinical Robustness of Digital Health Startups: cross-sectional Observational Analysis","volume":"24","author":"Day","year":"2022","journal-title":"J Med Internet Res"},{"issue":"2","key":"10.1016\/j.jcf.2023.04.015_bib0021","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1016\/j.jcf.2017.09.006","article-title":"Ivacaftor withdrawal syndrome in cystic fibrosis patients with the G551D mutation","volume":"17","author":"Trimble","year":"2018","journal-title":"J Cyst Fibros"},{"issue":"22","key":"10.1016\/j.jcf.2023.04.015_bib0022","first-page":"00434","article-title":"Discontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY): results from two parallel, multicentre, open-label, randomised, controlled, non-inferiority trials","volume":"S2213-2600","author":"Mayer-Hamblett","year":"2022","journal-title":"Lancet Respir Med"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199323001236?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199323001236?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T21:14:35Z","timestamp":1778620475000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199323001236"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S1569199323001236"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2023.04.015","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Partners in research: The success with therapies research consortium and the CF community unite to improve self-management","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2023.04.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 European Cystic Fibrosis Society. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}